Innovator Ibd 50 Etf Profile
| FFTY Etf | USD 31.23 0.15 0.48% |
Performance14 of 100
| Odds Of DistressLess than 9
|
Innovator IBD is trading at 31.23 as of the 28th of November 2024; that is 0.48 percent decrease since the beginning of the trading day. The etf's open price was 31.38. Innovator IBD has less than a 9 % chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. Equity ratings for Innovator IBD 50 are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of December 2022 and ending today, the 28th of November 2024. Click here to learn more.
The fund will normally invest at least 80 percent of its net assets in securities that comprise the index. Innovator Ibd is traded on NYSEARCA Exchange in the United States. More on Innovator IBD 50
Moving together with Innovator Etf
Innovator Etf Highlights
| Thematic Ideas | (View all Themes) |
| Business Concentration | Strategy ETFs, Broad Equity ETFs, Mid-Cap Growth, Innovator ETFs (View all Sectors) |
| Issuer | Innovator Capital Management |
| Inception Date | 2015-04-09 |
| Benchmark | IBD 50 Index |
| Entity Type | Regulated Investment Company |
| Asset Under Management | 76.83 Million |
| Average Trading Valume | 118,825 |
| Asset Type | Equity |
| Category | Broad Equity |
| Focus | Strategy |
| Market Concentration | Blended Development |
| Region | Global |
| Administrator | U.S. Bancorp Fund Services, LLC |
| Advisor | Innovator Capital Management, LLC |
| Custodian | U.S. Bank, N.A. |
| Distributor | Foreside Fund Services, LLC |
| Portfolio Manager | Dustin Lewellyn, Ernesto Tong, Anand Desai |
| Transfer Agent | U.S. Bancorp Fund Services, LLC |
| Fiscal Year End | 31-Oct |
| Exchange | NYSE Arca, Inc. |
| Number of Constituents | 51.0 |
| Market Maker | Virtu Financial |
| Total Expense | 1.09 |
| Management Fee | 0.7 |
| Country Name | USA |
| Returns Y T D | 28.76 |
| Name | Innovator IBD 50 ETF |
| Currency Code | USD |
| Open Figi | BBG008G60GX9 |
| In Threey Volatility | 26.54 |
| 1y Volatility | 20.29 |
| 200 Day M A | 27.1331 |
| 50 Day M A | 27.8954 |
| Code | FFTY |
| Updated At | 27th of November 2024 |
| Currency Name | US Dollar |
Innovator IBD 50 [FFTY] is traded in USA and was established 2015-04-08. The fund is listed under Mid-Cap Growth category and is part of Innovator ETFs family. The entity is thematically classified as Strategy ETFs. Innovator IBD 50 currently have 97.73 M in assets under management (AUM). , while the total return for the last 3 years was -11.9%.
Check Innovator IBD Probability Of Bankruptcy
Geographic Allocation (%)
Sector Allocation
Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on Innovator Etf. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding Innovator Etf, and the less return is expected.
Institutional investors that are interested in enforcing a sector tilt in their portfolio can use exchange-traded funds, such as Innovator IBD 50 Etf, as a low-cost alternative to building a custom portfolio. So, using sector ETFs to diversify your portfolio can be a profitable strategy. However, no matter what sectors are desirable at a given time, no single industry should ever make up more than 20 percent of your stock portfolio.
Top Innovator IBD 50 Etf Constituents
| ATHM | Autohome | Stock | Communication Services | |
| FTNT | Fortinet | Stock | Information Technology | |
| CPRT | Copart Inc | Stock | Industrials | |
| NXST | Nexstar Broadcasting Group | Stock | Communication Services | |
| ADBE | Adobe Systems Incorporated | Stock | Information Technology | |
| UPST | Upstart Holdings | Stock | Financials | |
| FND | Floor Decor Holdings | Stock | Consumer Discretionary | |
| OLED | Universal Display | Stock | Information Technology |
Innovator IBD Top Holders
| ADOAX | Acm Dynamic Opportunity | Mutual Fund | Options Trading | |
| ADOIX | Acm Dynamic Opportunity | Mutual Fund | Options Trading | |
| NAVFX | The Sector Rotation | Mutual Fund | Large Growth |
Innovator IBD 50 Risk Profiles
The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Innovator IBD. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.
| Risk Adjusted Performance | 0.1462 | |||
| Jensen Alpha | 0.093 | |||
| Total Risk Alpha | 0.0328 | |||
| Sortino Ratio | 0.1137 |
Innovator IBD Against Markets
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Innovator IBD 50. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
The market value of Innovator IBD 50 is measured differently than its book value, which is the value of Innovator that is recorded on the company's balance sheet. Investors also form their own opinion of Innovator IBD's value that differs from its market value or its book value, called intrinsic value, which is Innovator IBD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innovator IBD's market value can be influenced by many factors that don't directly affect Innovator IBD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innovator IBD's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innovator IBD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innovator IBD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.